Deals, M&A

Laboratory Corporation of America Holdings successfully completes acquisition of Genzyme Genetics for $925 Million

Posted on 01 December 2010

Tags: ,

Laboratory Corporation of America® Holdings has announced the successful completion of its acquisition of Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition-related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million. Read the full release on the acquisition of Genzyme Genetics at Current Agreements

Print Friendly, PDF & Email

Leave a Reply